SCHEMBL12608045

SCHEMBL12608045

C=CCNC(=O)C(=O)[C@@H]1CCCCCCCOC[C@H](NC(=O)NC2([C@H]3CCCS3(=O)=O)CCCCC2)C(=O)N2C[C@H]3[C@@H]([C@H]2C(=O)N1)C3(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12607156 0.93 — —
SCHEMBL12607795 0.93 — —
SCHEMBL12608418 0.93 — —
SCHEMBL8048194 0.93 — —
SCHEMBL12607968 0.93 — —
SCHEMBL12607970 0.93 — —
SCHEMBL12607972 0.90 — —
SCHEMBL12608422 0.87 — —
SCHEMBL8289630 0.84 PPIA (0.31) —
SCHEMBL8291490 0.84 PPIA (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110150835-A1 Macrocyclic Inhibitors of Hepatitis C Virus NS3 Serine Protease SCHERING CORPORATION 2011-06-23 — — US disclosed
Send feedback